BXOS110

· Biocells (Beijing) Biotech Co.,Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BXOS110, covering 2024-03-21 to 2024-03-21. Get the full timeline:

Most recent: Clinical Trial Update: BXOS110 Injection in the Treatment of Acute Ischaemic Stroke [Phase 2]